UK-based Unit1, which develops "hyper-realistic" digital avatars of musicians to recreate classic concerts, raised nearly £15M from Balderton Capital and others
THE SO WHAT
If Unit1 can make Abba Voyage–style shows cheaper and more repeatable, IP owners just got a new way to monetize catalogs without touring. For venues and promoters, this is a test case for whether “virtual legacy acts” can anchor real-world ticket revenue and off-peak inventory.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureMithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures
Biopharma is starting to pay for AI that plugs directly into existing R&D systems, not just standalone discovery tools. If Mithrl’s “biomedical world model” can sit in the loop with pharma workflows, expect procurement teams to favor vendors that integrate with ELNs, LIMS, and trial stacks out of the box.
Startups & VentureSoftBank Seeks Over $11 Billion in Junk Bonds for OpenAI Bet
When a conglomerate raises over $11B in junk bonds to double down on one AI platform, AI exposure is becoming a structured asset class, not just equity risk. CFOs with indirect OpenAI dependence should assume more financial engineering around core infra and model access—and model that counterparty and concentration risk explicitly.
Startups & Venture6 days left to get ahead at TechCrunch Disrupt 2026
Disrupt’s scale — 10,000+ founders and investors — is a reminder that signal-to-noise at conferences is collapsing. Treat events like this as targeted deal or recruiting trips, not strategy offsites.
Startups & VentureHoward Marks Flags Uncertainty in AI Investing
When Howard Marks is publicly stressing caution on AI enthusiasm, LPs and boards will start asking harder questions about AI exposure and payback periods. Founders should expect more scrutiny on unit economics and defensibility, not just “AI inside” narratives.